AREA SOCI

Password dimenticata?

DIVENTA SOCIO

La domanda di iscrizione alla SIGU verrà vagliata e approvata dal Consiglio Direttivo , dopo questa approvazione formale la segreteria provvederà all'inserimento nell'elenco soci dei nuovi nominativi e all'invio della corrispondenza di pertinenza.
Il versamento della quota associativa annua dovrà essere effettuato solo dopo l'accettazione della domanda di iscrizione alla Società. « continua »

Documenti

20 Ott 2010

Guideline on the use of pharmacogenetic methodologies in the pharmacokinetic evaluation of medicinal products

20 Ott 2010

Reflection paper on co-development of pharmacogenomics biomarkers and Assays in the context of drug development

20 Ott 2010
ICH guideline E16 Genomic biomarkers related to drug response: context, structure and format of qualification submissions
20 Ott 2010

Guideline on the use of pharmacogenetic methodologies in the pharmacokinetic evaluation of medicinal products

20 Ott 2010
Reflection paper on co-development of pharmacogenomics biomarkers and Assays in the context of drug development
08 Set 2010

Definitions:
Clinical validity in genetic testing is a measurement of the accuracy (such as clinical sensitivity and specificity as well as predictive value) with which a test identifies or predicts a clinical condition...

08 Set 2010

This project is carried out by the Institute of Technology Assessment, Research Centre Karlsruhe and the Flemish Institute of Technology Assessment, as members of the ETAG Group. It was commissioned under specific contract IP/A/STOA/FWC/2005-28/SC39.

08 Set 2010

THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION, Having regard to the Treaty establishing the European Community, and in particular Article 100a thereof,

08 Set 2010

SG1 Final Document GHTF/SG1/N045:2008

16 Ago 2010

DOCUMENTO DELLA "HUMAN GENETICS COMMISSION": UK Government's advisory body on new developments in human genetics.

Pagina 8 di 10